NM_001085352 // GO:0006629 // lipid metabolic process // inferred from electronic annotation  /// NM_001085352 // GO:0010518 // positive regulation of phospholipase activity // inferred from electronic annotation  /// NM_001085352 // GO:0010518 // positive regulation of phospholipase activity // not recorded  /// NM_001085352 // GO:0010898 // positive regulation of triglyceride catabolic process // inferred from electronic annotation  /// NM_001085352 // GO:0010898 // positive regulation of triglyceride catabolic process // not recorded  /// NM_001085352 // GO:0010916 // negative regulation of very-low-density lipoprotein particle clearance // inferred from electronic annotation  /// NM_001085352 // GO:0010916 // negative regulation of very-low-density lipoprotein particle clearance // not recorded  /// NM_001085352 // GO:0032375 // negative regulation of cholesterol transport // inferred from electronic annotation  /// NM_001085352 // GO:0032375 // negative regulation of cholesterol transport // not recorded  /// NM_001085352 // GO:0033344 // cholesterol efflux // inferred from electronic annotation  /// NM_001085352 // GO:0033344 // cholesterol efflux // not recorded  /// NM_001085352 // GO:0033700 // phospholipid efflux // inferred from electronic annotation  /// NM_001085352 // GO:0033700 // phospholipid efflux // not recorded  /// NM_001085352 // GO:0034382 // chylomicron remnant clearance // inferred from electronic annotation  /// NM_001085352 // GO:0034382 // chylomicron remnant clearance // not recorded  /// NM_001085352 // GO:0034384 // high-density lipoprotein particle clearance // inferred from electronic annotation  /// NM_001085352 // GO:0034384 // high-density lipoprotein particle clearance // not recorded  /// NM_001085352 // GO:0042493 // response to drug // inferred from expression pattern  /// NM_001085352 // GO:0042953 // lipoprotein transport // inferred from direct assay  /// NM_001085352 // GO:0043086 // negative regulation of catalytic activity // inferred from electronic annotation  /// NM_001085352 // GO:0043086 // negative regulation of catalytic activity // not recorded  /// NM_001085352 // GO:0045723 // positive regulation of fatty acid biosynthetic process // inferred from electronic annotation  /// NM_001085352 // GO:0045723 // positive regulation of fatty acid biosynthetic process // not recorded  /// NM_001085352 // GO:0045833 // negative regulation of lipid metabolic process // inferred from electronic annotation  /// NM_001085352 // GO:0045833 // negative regulation of lipid metabolic process // not recorded  /// NM_001085352 // GO:0048261 // negative regulation of receptor-mediated endocytosis // inferred from electronic annotation  /// NM_001085352 // GO:0048261 // negative regulation of receptor-mediated endocytosis // not recorded  /// NM_001085352 // GO:0051006 // positive regulation of lipoprotein lipase activity // inferred from electronic annotation  /// NM_001085352 // GO:0051006 // positive regulation of lipoprotein lipase activity // not recorded  /// NM_001085352 // GO:0060697 // positive regulation of phospholipid catabolic process // inferred from electronic annotation  /// NM_001085352 // GO:0060697 // positive regulation of phospholipid catabolic process // not recorded  /// NM_001085352 // GO:0070328 // triglyceride homeostasis // inferred from electronic annotation  /// NM_001085352 // GO:0070328 // triglyceride homeostasis // not recorded  /// NM_001085352 // GO:0006869 // lipid transport // inferred from electronic annotation  /// XM_006228403 // GO:0006629 // lipid metabolic process // inferred from electronic annotation  /// XM_006228403 // GO:0010518 // positive regulation of phospholipase activity // inferred from electronic annotation  /// XM_006228403 // GO:0010518 // positive regulation of phospholipase activity // not recorded  /// XM_006228403 // GO:0010898 // positive regulation of triglyceride catabolic process // inferred from electronic annotation  /// XM_006228403 // GO:0010898 // positive regulation of triglyceride catabolic process // not recorded  /// XM_006228403 // GO:0010916 // negative regulation of very-low-density lipoprotein particle clearance // inferred from electronic annotation  /// XM_006228403 // GO:0010916 // negative regulation of very-low-density lipoprotein particle clearance // not recorded  /// XM_006228403 // GO:0032375 // negative regulation of cholesterol transport // inferred from electronic annotation  /// XM_006228403 // GO:0032375 // negative regulation of cholesterol transport // not recorded  /// XM_006228403 // GO:0033344 // cholesterol efflux // inferred from electronic annotation  /// XM_006228403 // GO:0033344 // cholesterol efflux // not recorded  /// XM_006228403 // GO:0033700 // phospholipid efflux // inferred from electronic annotation  /// XM_006228403 // GO:0033700 // phospholipid efflux // not recorded  /// XM_006228403 // GO:0034382 // chylomicron remnant clearance // inferred from electronic annotation  /// XM_006228403 // GO:0034382 // chylomicron remnant clearance // not recorded  /// XM_006228403 // GO:0034384 // high-density lipoprotein particle clearance // inferred from electronic annotation  /// XM_006228403 // GO:0034384 // high-density lipoprotein particle clearance // not recorded  /// XM_006228403 // GO:0042493 // response to drug // inferred from expression pattern  /// XM_006228403 // GO:0042953 // lipoprotein transport // inferred from direct assay  /// XM_006228403 // GO:0043086 // negative regulation of catalytic activity // inferred from electronic annotation  /// XM_006228403 // GO:0043086 // negative regulation of catalytic activity // not recorded  /// XM_006228403 // GO:0045723 // positive regulation of fatty acid biosynthetic process // inferred from electronic annotation  /// XM_006228403 // GO:0045723 // positive regulation of fatty acid biosynthetic process // not recorded  /// XM_006228403 // GO:0045833 // negative regulation of lipid metabolic process // inferred from electronic annotation  /// XM_006228403 // GO:0045833 // negative regulation of lipid metabolic process // not recorded  /// XM_006228403 // GO:0048261 // negative regulation of receptor-mediated endocytosis // inferred from electronic annotation  /// XM_006228403 // GO:0048261 // negative regulation of receptor-mediated endocytosis // not recorded  /// XM_006228403 // GO:0051006 // positive regulation of lipoprotein lipase activity // inferred from electronic annotation  /// XM_006228403 // GO:0051006 // positive regulation of lipoprotein lipase activity // not recorded  /// XM_006228403 // GO:0060697 // positive regulation of phospholipid catabolic process // inferred from electronic annotation  /// XM_006228403 // GO:0060697 // positive regulation of phospholipid catabolic process // not recorded  /// XM_006228403 // GO:0070328 // triglyceride homeostasis // inferred from electronic annotation  /// XM_006228403 // GO:0070328 // triglyceride homeostasis // not recorded  /// XM_006228403 // GO:0006869 // lipid transport // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0006629 // lipid metabolic process // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0010518 // positive regulation of phospholipase activity // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0010518 // positive regulation of phospholipase activity // not recorded  /// ENSRNOT00000024800 // GO:0010898 // positive regulation of triglyceride catabolic process // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0010898 // positive regulation of triglyceride catabolic process // not recorded  /// ENSRNOT00000024800 // GO:0010916 // negative regulation of very-low-density lipoprotein particle clearance // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0010916 // negative regulation of very-low-density lipoprotein particle clearance // not recorded  /// ENSRNOT00000024800 // GO:0032375 // negative regulation of cholesterol transport // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0032375 // negative regulation of cholesterol transport // not recorded  /// ENSRNOT00000024800 // GO:0033344 // cholesterol efflux // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0033344 // cholesterol efflux // not recorded  /// ENSRNOT00000024800 // GO:0033700 // phospholipid efflux // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0033700 // phospholipid efflux // not recorded  /// ENSRNOT00000024800 // GO:0034382 // chylomicron remnant clearance // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0034382 // chylomicron remnant clearance // not recorded  /// ENSRNOT00000024800 // GO:0034384 // high-density lipoprotein particle clearance // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0034384 // high-density lipoprotein particle clearance // not recorded  /// ENSRNOT00000024800 // GO:0042493 // response to drug // inferred from expression pattern  /// ENSRNOT00000024800 // GO:0042953 // lipoprotein transport // inferred from direct assay  /// ENSRNOT00000024800 // GO:0043086 // negative regulation of catalytic activity // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0043086 // negative regulation of catalytic activity // not recorded  /// ENSRNOT00000024800 // GO:0045723 // positive regulation of fatty acid biosynthetic process // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0045723 // positive regulation of fatty acid biosynthetic process // not recorded  /// ENSRNOT00000024800 // GO:0045833 // negative regulation of lipid metabolic process // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0045833 // negative regulation of lipid metabolic process // not recorded  /// ENSRNOT00000024800 // GO:0048261 // negative regulation of receptor-mediated endocytosis // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0048261 // negative regulation of receptor-mediated endocytosis // not recorded  /// ENSRNOT00000024800 // GO:0051006 // positive regulation of lipoprotein lipase activity // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0051006 // positive regulation of lipoprotein lipase activity // not recorded  /// ENSRNOT00000024800 // GO:0060697 // positive regulation of phospholipid catabolic process // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0060697 // positive regulation of phospholipid catabolic process // not recorded  /// ENSRNOT00000024800 // GO:0070328 // triglyceride homeostasis // inferred from electronic annotation  /// ENSRNOT00000024800 // GO:0070328 // triglyceride homeostasis // not recorded  /// ENSRNOT00000024800 // GO:0006869 // lipid transport // inferred from electronic annotation  /// FQ209611 // GO:0006629 // lipid metabolic process // inferred from electronic annotation  /// FQ209611 // GO:0010518 // positive regulation of phospholipase activity // inferred from electronic annotation  /// FQ209611 // GO:0010518 // positive regulation of phospholipase activity // not recorded  /// FQ209611 // GO:0010898 // positive regulation of triglyceride catabolic process // inferred from electronic annotation  /// FQ209611 // GO:0010898 // positive regulation of triglyceride catabolic process // not recorded  /// FQ209611 // GO:0010916 // negative regulation of very-low-density lipoprotein particle clearance // inferred from electronic annotation  /// FQ209611 // GO:0010916 // negative regulation of very-low-density lipoprotein particle clearance // not recorded  /// FQ209611 // GO:0032375 // negative regulation of cholesterol transport // inferred from electronic annotation  /// FQ209611 // GO:0032375 // negative regulation of cholesterol transport // not recorded  /// FQ209611 // GO:0033344 // cholesterol efflux // inferred from electronic annotation  /// FQ209611 // GO:0033344 // cholesterol efflux // not recorded  /// FQ209611 // GO:0033700 // phospholipid efflux // inferred from electronic annotation  /// FQ209611 // GO:0033700 // phospholipid efflux // not recorded  /// FQ209611 // GO:0034382 // chylomicron remnant clearance // inferred from electronic annotation  /// FQ209611 // GO:0034382 // chylomicron remnant clearance // not recorded  /// FQ209611 // GO:0034384 // high-density lipoprotein particle clearance // inferred from electronic annotation  /// FQ209611 // GO:0034384 // high-density lipoprotein particle clearance // not recorded  /// FQ209611 // GO:0042493 // response to drug // inferred from expression pattern  /// FQ209611 // GO:0042953 // lipoprotein transport // inferred from direct assay  /// FQ209611 // GO:0043086 // negative regulation of catalytic activity // inferred from electronic annotation  /// FQ209611 // GO:0043086 // negative regulation of catalytic activity // not recorded  /// FQ209611 // GO:0045723 // positive regulation of fatty acid biosynthetic process // inferred from electronic annotation  /// FQ209611 // GO:0045723 // positive regulation of fatty acid biosynthetic process // not recorded  /// FQ209611 // GO:0045833 // negative regulation of lipid metabolic process // inferred from electronic annotation  /// FQ209611 // GO:0045833 // negative regulation of lipid metabolic process // not recorded  /// FQ209611 // GO:0048261 // negative regulation of receptor-mediated endocytosis // inferred from electronic annotation  /// FQ209611 // GO:0048261 // negative regulation of receptor-mediated endocytosis // not recorded  /// FQ209611 // GO:0051006 // positive regulation of lipoprotein lipase activity // inferred from electronic annotation  /// FQ209611 // GO:0051006 // positive regulation of lipoprotein lipase activity // not recorded  /// FQ209611 // GO:0060697 // positive regulation of phospholipid catabolic process // inferred from electronic annotation  /// FQ209611 // GO:0060697 // positive regulation of phospholipid catabolic process // not recorded  /// FQ209611 // GO:0070328 // triglyceride homeostasis // inferred from electronic annotation  /// FQ209611 // GO:0070328 // triglyceride homeostasis // not recorded  /// FQ209611 // GO:0006869 // lipid transport // inferred from electronic annotation